These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6233396

  • 1. Potential for specific cancer therapy with immune T lymphocytes.
    Cheever MA, Greenberg PD, Fefer A.
    J Biol Response Mod; 1984; 3(2):113-27. PubMed ID: 6233396
    [Abstract] [Full Text] [Related]

  • 2. Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2.
    Greenberg PD, Cheever MA.
    J Biol Response Mod; 1984 Oct; 3(5):455-61. PubMed ID: 6239012
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA, Greenberg PD, Irle C, Thompson JA, Urdal DL, Mochizuki DY, Henney CS, Gillis S.
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo.
    Cheever MA, Thompson JA, Kern DE, Greenberg PD.
    J Biol Response Mod; 1984 Oct; 3(5):462-7. PubMed ID: 6334133
    [Abstract] [Full Text] [Related]

  • 5. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K, Pellis NR, Kahan BD.
    Cancer Res; 1988 Jan 01; 48(1):101-8. PubMed ID: 3257158
    [Abstract] [Full Text] [Related]

  • 6. Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo.
    Cheever MA, Klarnet JP, Peace DJ, Greenberg PD.
    Prog Clin Biol Res; 1987 Jan 01; 244():49-58. PubMed ID: 3498958
    [Abstract] [Full Text] [Related]

  • 7. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
    Greenberg P, Klarnet J, Kern D, Okuno K, Riddell S, Cheever M.
    Princess Takamatsu Symp; 1988 Jan 01; 19():287-301. PubMed ID: 2479634
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothée G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S.
    Cancer; 2001 Jan 01; 91(1):113-22. PubMed ID: 11148567
    [Abstract] [Full Text] [Related]

  • 13. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD, Cheever MA.
    J Immunol; 1984 Dec 01; 133(6):3401-7. PubMed ID: 6149246
    [Abstract] [Full Text] [Related]

  • 14. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
    den Boer AT, van Mierlo GJ, Fransen MF, Melief CJ, Offringa R, Toes RE.
    Cancer Res; 2005 Aug 01; 65(15):6984-9. PubMed ID: 16061684
    [Abstract] [Full Text] [Related]

  • 15. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P, De Meyer M, Leroy P, Rousseau C, Acres B.
    Cancer Gene Ther; 2001 May 15; 8(5):321-32. PubMed ID: 11477452
    [Abstract] [Full Text] [Related]

  • 18. Local T helper cell signals by lymphocytes infiltrating intraocular tumors.
    Ksander BR, Acevedo J, Streilein JW.
    J Immunol; 1992 Mar 15; 148(6):1955-63. PubMed ID: 1531848
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, Proietti E.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.